from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3119/moaE1

LFCtreatmentdescriptionclass of inhibitor

0.123

Amikacinug/mL Amikacintranslation

0.348

Cap5-10ug/mL Capreomycintranslation

-0.042

Rox10-50 ug/mL Roxithromycintranslation

0.030

SM2-5 ug/mL Streptomycintranslation

0.591

Tet5-10 ug/mL Tetracyclinetranslation

0.402

Rif0.2-5ug/mL Rifampicintranscription

-0.070

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.025

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.256

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.128

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.475

Clofazimine10-13 ug/mL Clofaziminerespiration

0.336

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.651

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.317

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.828

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.143

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.707

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.527

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.189

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.149

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.111

KCN5-20 ug/mL Potassium cyaniderespiration

-0.609

NaN30.2-2 mM Sodium aziderespiration

-0.842

Nigericin50 uM Nigericinrespiration

-0.582

TRC10-150 ug/mL Triclosanrespiration

0.441

TRZ10-25 ug/mL Thioridazinerespiration

-1.075

Valinomycin0.5-10 uM Valinomycinrespiration

-0.124

ZnSO42 mM ZnSO4respiration

1.362

menadione6-10 ug/mL Menadionerespiration

-0.300

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.210

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.127

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.749

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.182

NRP_1Non-replicating persistence stage 1dosRassociated

0.217

Amp0.2mg/mL AmpicillincellWall

0.957

Cephalexin20-100 ug/mL CephalexincellWall

-0.229

Cerulenin0.32-5 ug/mL CerulenincellWall

0.673

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.094

EMB10-20 ug/mL EthambutolcellWall

0.145

Eta12-40 ug/mL EthionamidecellWall

-0.236

INH0.2-0.4 ug/mL IsoniazidcellWall

0.413

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.986

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.567

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.759

BZA0.12 mg/mL BenzamidearomaticAmides

-0.812

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.546

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.130

H2O24 mM hydrogen peroxideDNAdamaging

-0.026

Levo10 ug/mL LevofloxacinDNAdamaging

-0.413

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.376

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.472

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.031

UVUV-irradiationDNAdamaging

0.901

ARP41-4 ug/mL Antitubercular compound ARP4?

0.209

Antimycin12.5-50 ug/mL Antimycin A?

0.476

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.389

PA_110-50 ug/mL Antitubercular compound PA-1?

0.799

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.024

PA8240.2-2 ug/mL PA-824?

-1.181

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.010

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.443

Verapamil50 uM Verapamil?

1.346

mercaptoethanol2 mM 2-Mercaptoethanol?

0.618

methoxatin10-20 ug/mL Methoxatin?